Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery
NCT02012946Phase 4Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Dec 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in cardiovascular disease (CVD), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Status: unknown.
02
Drugs
levosimendan
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02012946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012946.